Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.15 USD | -4.60% | +8.36% | -3.26% |
May. 08 | BofA Securities Starts Sutro Biopharma With Buy Rating | MT |
Apr. 30 | Sutro Biopharma, Inc. Announces Initiation of Randomized Portion (Part 2) of REFRaME-O1 Trial | CI |
Financials (USD)
Sales 2024 * | 70.71M | Sales 2025 * | 60.63M | Capitalization | 339M |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -262M | EV / Sales 2024 * | 2.48 x |
Net cash position 2024 * | 164M | Net cash position 2025 * | 368M | EV / Sales 2025 * | -0.47 x |
P/E ratio 2024 * |
-1.26
x | P/E ratio 2025 * |
-1.28
x | Employees | 302 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.08% |
Latest transcript on Sutro Biopharma, Inc.
1 day | -4.60% | ||
1 week | +8.36% | ||
Current month | +22.24% | ||
1 month | +0.24% | ||
3 months | -14.96% | ||
6 months | +99.52% | ||
Current year | -3.26% |
Managers | Title | Age | Since |
---|---|---|---|
William Newell
CEO | Chief Executive Officer | 66 | 09-01-13 |
Jane Chung
PSD | President | 53 | 21-08-08 |
Edward Albini
DFI | Director of Finance/CFO | 66 | 13-01-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Connie Matsui
CHM | Chairman | 70 | 19-06-23 |
James Panek
BRD | Director/Board Member | 71 | 20-01-06 |
Daniel Petree
BRD | Director/Board Member | 68 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | +9.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4.15 | -4.60% | 356,809 |
24-05-09 | 4.35 | +1.64% | 585,826 |
24-05-08 | 4.28 | +0.71% | 1,158,835 |
24-05-07 | 4.25 | +9.25% | 570,944 |
24-05-06 | 3.89 | +1.57% | 513,887 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.26% | 339M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.12% | 22.25B | |
-13.14% | 22.09B | |
-7.56% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- STRO Stock